Sex differences in cardiac risk and kidney function: serum creatinine versus cystatin C
Measurement of cystatin C improves estimation of cardiac risk associated with kidney function, particularly for females. Incorporating eGFRCys, rather than eGFRCr, into cardiovascular risk assessment may be more important for early detection and management of high-risk females with CKD.
Authors
- Brenda Rosales (ORCID: https://orcid.org/0000-0002-9044-761X)
- Angela C Webster (ORCID: https://orcid.org/0000-0001-7509-0512)
- Patrick Barry Mark (ORCID: https://orcid.org/0000-0003-3387-2123)
- James Hedley (ORCID: https://orcid.org/0000-0002-6077-0862)
- Jennifer Susan Lees (ORCID: https://orcid.org/0000-0001-6331-0178)
- Nicole De La Mata
- Michael K. Sullivan
Institutions
- The University of Sydney (AU)
- Westmead Hospital (AU)
- University of Glasgow (GB)
Publication Details
- Journal
- BMC Medicine
- Published
- 2025-12-30
- DOI
- https://doi.org/10.1186/s12916-025-04588-9
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00